Advancing DMT into a Phase 1 Clinical Trial

Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial
Healthcare

Algernon is focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

October 28, 2022